Clinical Trial Update: The Efficacy of Potassium-competitive Acid Blocker in Patients With Laryngopharyngeal Reflux Disease [Phase 3]

View source ↗

Summary

Phase 3 trial updating on the efficacy of a potassium-competitive acid blocker for laryngopharyngeal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngopharyngeal Reflux Disease

Drugs mentioned

• Potassium-Competitive Acid Blocker (potassium-competitive acid blocker)

Snippet

Sponsor: Pusan National University Hospital | Conditions: Laryngopharyngeal Reflux Disease | Phase 3 | Status: COMPLETED